Plain-English translation of NCT02594202 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This is a research study run by the National Cancer Institute that collects blood, urine, saliva, and prostate tissue samples from men with prostate cancer or suspected prostate cancer. Researchers will study these samples to better understand how prostate cancer develops at the genetic and molecular level, which may help doctors develop new targeted treatments in the future.
Prostate cancer is very common—about 1 in 6 men will be diagnosed in their lifetime. By studying the genetics and biology of prostate cancer tissue, researchers hope to identify new drug targets and personalized treatment strategies, similar to advances that have already helped patients with kidney cancer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will provide samples—blood, urine, saliva, and possibly prostate tissue—at the time you're already scheduled for diagnostic or treatment procedures related to your prostate cancer care. Researchers will also collect additional blood and urine samples at follow-up visits. Your samples will be studied in the laboratory, and the researchers may track your health outcomes over time to understand how the genetic features of your cancer relate to how your disease progresses. Most of the participation happens during appointments you're already planning to have as part of your regular cancer care.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States